<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02691546</url>
  </required_header>
  <id_info>
    <org_study_id>INRCA_01_2016</org_study_id>
    <secondary_id>Grant Agreement n. 634869</secondary_id>
    <nct_id>NCT02691546</nct_id>
  </id_info>
  <brief_title>Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)</brief_title>
  <acronym>SCOPE</acronym>
  <official_title>Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Nazionale di Ricovero e Cura per Anziani</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ben-Gurion University of the Negev</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Servicio Madrileño de Salud, Madrid, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut Catala de Salut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UNIVERSYTET MEDYCZNY W LODZI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>FRIEDRICH-ALEXANDER-UNIVERSITAT ERLANGEN NURNBERG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UPPSALA UNIVERSITET</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istituto Nazionale di Ricovero e Cura per Anziani</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SCOPE study is an observational, multicenter, prospective cohort study aimed at
      evaluating a 2-year screening programme for CKD in a population of older patients, aged 75
      years or more, in seven European Countries, in an attempt to investigate whether and to which
      extent currently available screening methods may identify older people at risk of worsening
      kidney function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 8, 2016</start_date>
  <completion_date type="Actual">March 10, 2020</completion_date>
  <primary_completion_date type="Actual">March 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of estimated Glomerular Filtration Rate (eGFR) decline</measure>
    <time_frame>24 months</time_frame>
    <description>eGFR will be calculated using the Berlin Initiative Study 1 (BIS1) equation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of End Stage Renal Disease (ESRD)</measure>
    <time_frame>24 months</time_frame>
    <description>ESRD will be defined as eGFR&lt;15 mL/min/1.73 m2 or dialysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of kidney function</measure>
    <time_frame>Baseline and 24 months</time_frame>
    <description>cystatin C, beta2-microglobulin, beta-trace protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetic and epigenetic analyses</measure>
    <time_frame>Baseline and 24 months</time_frame>
    <description>circulating microRNA, telomere length in circulating leukocytes, DNA methylation, analysis of the whole genome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of CKD complications</measure>
    <time_frame>24 months</time_frame>
    <description>anemia, hyperphosphatemia, acidosis, hypoalbuminemia, hyperparathyroidism, hyperkaliemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major comorbidities</measure>
    <time_frame>24 months</time_frame>
    <description>myocardial infarction, hospitalization for unstable angina, transient ischemic attack/stroke, heart failure events, interventional cardiology events, peripheral vascular intervention, and stent thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>24 months</time_frame>
    <description>death resulting from acute myocardial infarction, sudden cardiac death, heart failure, stroke, CV procedures, CV hemorrhage, and other CV causes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehensive geriatric assessment (CGA)</measure>
    <time_frame>Baseline and 24 months</time_frame>
    <description>Cognitive function (Mini Mental State Examination), depression (Geriatric Depression Scale), functional assessment (Basic Activity of Daily Living, Lawton Instrumental Activities of Daily Living Scale), health status (Cumulative Illness Rating Scale for Geriatrics), risk of malnutrition (Mini Nutritional Assessment), dietary intake assessment (24-h Dietary Recall), history of falls and incident falls, vision and hearing impairment, socioeconomic Status, physical Performance (Short Physical Performance Battery Test), muscle strength (Hand Grip Strength), quality of life (Euro-Qol 5D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Healthcare resource consumption</measure>
    <time_frame>Baseline and 24 months</time_frame>
    <description>previous physician visits, use of care services, hospital admissions, laboratory tests performed</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2434</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Subjects aged 75 years or older</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample collection</intervention_name>
    <arm_group_label>Subjects aged 75 years or older</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma, serum, whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        subjects with 75 years or older
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age≥75 years

          -  subjects attending the outpatient services at participating institutions

        Exclusion Criteria:

          -  ESRD or dialysis

          -  history of solid organ or bone marrow transplantation

          -  active malignancy within 24 months prior to screening or metastatic cancer

          -  life expectancy less than 6 months

          -  severe cognitive impairment (MMSE&lt;10),

          -  any medical or other reason that the subject is unsuitable for the study

          -  subjects unwilling to provide consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>MEDIZINISCHE UNIVERSITAT- Internal Medicine/Nephrology/Geriatric Department</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FRIEDRICH-ALEXANDER-UNIVERSITAT-Institute for Biomedicine of Aging</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BEN-GURION UNIVERSITY-Geriatrics Department</name>
      <address>
        <city>Beer Sheva</city>
        <zip>84105</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INRCA Research Hospital</name>
      <address>
        <city>Ancona</city>
        <zip>60131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INRCA Research Hospital</name>
      <address>
        <city>Cosenza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ERASMUS UNIVERSITAIR MEDISCH CENTRUM-Department of Internal Medicine</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNIVERSYTET MEDYCZNY-Department of Geriatrics</name>
      <address>
        <city>Lodz</city>
        <zip>90419</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INSTITUT CATALA DE LA SALUT-Internal Medicine Deparment</name>
      <address>
        <city>Barcelona</city>
        <zip>08007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SERVICIO MADRILENO DE SALUD-Geriatric Department</name>
      <address>
        <city>Madrid</city>
        <zip>28020</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>February 20, 2016</study_first_submitted>
  <study_first_submitted_qc>February 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2016</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Kidney Diseases</keyword>
  <keyword>Older</keyword>
  <keyword>Geriatric assessment</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

